Daclatasvir in combination with sofosbuvir with or without ribavirin is safe and efficacious in liver transplant recipients with HCV recurrence : Interim results of a multicenter compassionate use program

Authors :: Herzer, Kerstin
Welzel, T. M.
Ferenci, P.
Petersen, J.
Gschwantler, M.
Cornberg, M.
Berg, T.
Spengler, U.
Weiland, O.
van der Valk, M.
Klinker, H.
Rockstroh, J. K.
Schott, E.
Peck-Radosavljevic, M.
Zhao, Y.
Exposito, M. J. J.
Zeuzem, S.
Publication Year :: 2015

Tools